NOWDiagnostics (NOWDx), a US-based medical technology startup developing over-the-counter (OTC) and point-of-care (POC) diagnostic test kits, has secured $22.5M in an oversubscribed series B funding round to commercialize at-home diagnostic testing kits. As the company announced on Tuesday, July 9, the new funding will also support the development of new diagnostic innovations, increase the number NOWDiagnostics (NOWDx) will use the capital to support the development, testing, and commercialization of innovative diagnostic test kits and hire more staff.
read more..